Selective Two-staged Hybrid Coronary Revascularization for Patients with Multivessel Coronary Artery Disease

吴松,凌云鹏,傅元豪,张鲁锋,杨航,郭丽君,王贵松,崔鸣,牛杰,高炜,万峰
DOI: https://doi.org/10.3969/j.issn.1009-6604.2017.02.005
2017-01-01
Abstract:Objective To discuss and investigate the safety and feasibility of two-staged hybrid coronary revascularization ( HCR) technique to treat multivessel coronary artery disease . Methods A total of 73 patients who underwent two-staged hybrid technique in our heart center because of coronary multivessel lesions from May 2012 to August 2014 were included retrospectively . Another 383 patients who underwent conventional off-pump coronary artery bypass ( OPCAB) by the same surgeon at the same period were selected as the control .There was no significant difference in preoperative situation between the two groups .Perioperative period and follow-up results were compared between the two groups . Results As compared to the OPCAB group , the HCR group had less operation duration [(152.9 ±43.8) min vs.(262.6 ±51.8) min, t=-16.993, P=0.000], bleeding [median, 460 (rang, 20-2070) ml vs.980 (130-8770) ml, Z=-8.232, P=0.000], blood transfusion [12 cases (16.4%) vs.200 cases (52.2%),χ2 =31.555, P=0.000], and mechanical ventilation [(9.4 ±7.4) h vs.(19.0 ±18.3) h, t=-4.391, P=0.000].The HCR group was followed in 73 cases ( 100%) , and the OPCAB group was followed in 360 cases ( 94.0%) .There was no significant difference in follow-up time between the two groups [(25.0 ±9.6) months vs.(22.8 ±10.6) months,t=1.693,P=0.091].The incidence of major adverse cardiac or cerebrovascular events (MACCE) rate was similar between the two groups [4 cases (5.5%) vs. 10 cases (2.8%), χ2 =0.684, P=0.408].The survival curve was similar between the two groups ( log-rank χ2 =1.041, P=0.308). Conclusion The two-staged hybrid coronary revascularization technique is safe and feasible for the treatment of multivessel coronary artery disease .
What problem does this paper attempt to address?